Recent SEC Filings
| Entity | Filing | Filed On |
|---|---|---|
| Acurx Pharmaceuticals Inc | FORM 8-K | 13 Nov 2024 |
| Wag! Group Co | 8-K | 13 Nov 2024 |
| Venus Concept Inc | 8-K | 13 Nov 2024 |
| Fulcrum Therapeutics Inc | 8-K | 13 Nov 2024 |
| /entities/flut | 8-K | 13 Nov 2024 |
| Syros Pharmaceuticals Inc | 8-K | 13 Nov 2024 |
| Leap Therapeutics Inc | FORM 8-K | 13 Nov 2024 |
| Air Industries Group | FORM 8-K | 13 Nov 2024 |
| Passage Bio Inc | 8-K | 13 Nov 2024 |
| Acrivon Therapeutics Inc | 8-K | 13 Nov 2024 |
| Broadwind Inc | FORM 8-K | 13 Nov 2024 |
| Predictive Oncology Inc | FORM 8-K | 13 Nov 2024 |
| ARS Pharmaceuticals Inc | 8-K | 13 Nov 2024 |
| QXO Inc | 8-K | 13 Nov 2024 |
| Entero Therapeutics Inc | FORM 8-K | 13 Nov 2024 |
| Instil Bio Inc | 8-K | 13 Nov 2024 |
| Mural Oncology PLC | 8-K | 13 Nov 2024 |
| Sila Realty Trust Inc | 8-K | 13 Nov 2024 |
| Liquidia Corp | FORM 8-K | 13 Nov 2024 |
| Sound Point Meridian Capital Inc | 8-K | 13 Nov 2024 |
